Kay AH, et al. - Researchers undertook this retrospective cohort analysis to define how postdischarge narcotic use in patients with ovarian cancer undergoing open surgery is influenced by an ERAS pathway. For this purpose, they analyzed women managed with open ovarian cancer surgeries in 2014 before ERAS (“pre-ERAS”) and in 2016/2018 after ERAS was instituted (“ERAS”). They did not include cases receiving chronic narcotics. Overall 42 pre-ERAS and 94 ERAS patients were incorporated in this analysis. In terms of age, BMI, diabetes, tobacco use, mean number of prior abdominal/pelvic surgeries, and advanced stage disease, the groups were found to be similar. A shorter hospital stay was experienced by ERAS patients, who also filled prescriptions at time of discharge for less narcotic. Compared with the pre-ERAS group, ERAS patients filled prescriptions for 55% fewer narcotics in the three months post-operation. Overall, a reduction in the narcotic requirements of patients in the three months post- ovarian cancer surgery was noted in relation to the institution of an ERAS protocol.